Cargando…
PARP inhibition utilized in combination therapy with Olaparib‐Temozolomide to achieve disease stabilization in a rare case of BRCA1‐mutant, metastatic myxopapillary ependymoma
Myxopapillary ependymoma (MPE) is a primary tumor of the central nervous system (CNS), characteristically an indolent malignancy involving the spinal conus medullaris, Filum terminale or cauda equina. We present a rare case of MPE, recurrent in the pelvic soft tissue with eventual pleural and intra-...
Autores principales: | Mahalingam, Preethika, Smith, Sam, Lopez, Juanita, Sharma, Rajaei K, Millard, Thomas, Thway, Khin, Fisher, Cyril, Reardon, David A, Jones, Robin, Nicholson, Andrew G, Cunningham, David, Welsh, Liam, Sharma, Bhupinder |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869186/ https://www.ncbi.nlm.nih.gov/pubmed/36698626 http://dx.doi.org/10.1177/20363613231152333 |
Ejemplares similares
-
Myxopapillary Ependymoma of the Sacrum
por: Goossens, Arnaud R., et al.
Publicado: (2023) -
Adjunctive treatment of myxopapillary ependymoma
por: Jahanbakhshi, Amin, et al.
Publicado: (2021) -
Sacrococcygeal myxopapillary ependymoma with anaplastic ependymoma component in an infant
por: Chakraborti, Shrijeet, et al.
Publicado: (2012) -
Stabilization of metastatic myxopapillary ependymoma with sorafenib
por: Fegerl, Gundula, et al.
Publicado: (2012) -
Giant myxopapillary ependymoma of the lumbosacral spine
por: El Kacemi, Inas, et al.
Publicado: (2021)